-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
November 01, 2014 - Potential harms also include side effects or complications of treatments. … Long-term harms of HIV antiretroviral therapy.
Sexually transmitted
infections
2. … Studies are needed that include psychotherapy and combined treatments
and focus on MDD alone, as well … inhibitors and complementary or alternative treatments). … Studies on the effectiveness of antiretroviral therapy, adherence to treatment, and
behavioral counseling
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hepatitis-c-screening
December 21, 2017 - What are the harms of currently recommended antiviral treatments? *
9. … 7, and 8 include those defined by age, race/ethnicity, sex, drug use, receipt of maximally assisted therapy … clinical outcomes (KQ 9)
Populations
Persons with HCV infection being treated with antiviral therapy … behavioral health care; subpopulations of interest include drug use, persons using medication-assisted therapies … age; morbidity outcomes include extrahepatic manifestations of HCV infection, such as depression and diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
January 01, 1996 - factors for coronary heart disease are smoking, high blood pressure, elevated serum cholesterol, obesity, diabetes … discuss aspirin prophylaxis with men who have risk factors for MI (e.g., high blood cholesterol, smoking, diabetes … risks of aspirin therapy before beginning treatment. … Foster JW, Hart RG Antithrombotic therapy for cerebrovascular disease: prevention and treatment of stroke … Fuster V, Dyken ML, Vokonas PS, et al Aspirin as a therapeutic agent in cardiovascular disease.
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-iii-uspstf-litwatch-process
April 01, 2019 - Topics of interest include screening, preventive services, effectiveness of early treatment of screen-detected … College of Preventive Medicine
American Osteopathic Association
American Cancer Society
American Diabetes
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/N3VeYbr4ZdhZfqsw3ErLHE
November 01, 2014 - Other factors, including
treatment and control of diabetes and hyperlipidemia, are
also reported to be … beyond current standard medical therapy. … Prevalence of hypertension in CREST
and the SAPPHIRE trial was 85% to 88%, prevalence of
diabetes in … and benefit beyond
standard preventive treatments based on traditional cardio-
vascular risk factors … of medical
and surgical treatments, including the potential incremen-
tal benefit of CEA.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-for-cvd-prevention-in-adults-2012
June 15, 2012 - Recommendation
Grade
General adult population without a known diagnosis of hypertension, diabetes … Population
General adult population without a known diagnosis of hypertension, diabetes … available to quantify a person's 10-year risk for cardiac events, such as the Framingham-based Adult Treatment … It does not apply to adults who have known CVD, hypertension, hyperlipidemia, or diabetes. … The Framingham-based Adult Treatment Panel III calculator (available at https://hp2010.nhlbihin.net/
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-children-screening
July 18, 2023 - Dyslipidemia due to homozygous FH or secondary causes (such as diabetes, nephrotic syndrome, or hypothyroidism … USPSTF reviewed 22 fair- to good-quality trials (n = 2257) examining the effectiveness of lipid-lowering treatments … good-quality trials (n = 1008) examining the effectiveness of various nonpharmacologic lipid-lowering treatments … A fair-quality observational study (n = 9393) evaluating the association of statins and new-onset diabetes … showed no difference in new diabetes diagnoses over up to 9 years of follow-up in individuals taking
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
March 15, 2009 - Thus, decisions about aspirin therapy should consider the overall risk for stroke and gastrointestinal … Treatment
The optimum dose of aspirin for preventing cardiovascular disease events is not known. … among persons whose risk is sufficiently high for the benefits to outweigh the risks associated with treatment … prevention of stroke in women whose risk is sufficiently high for the benefits to outweigh the harms of treatment … from the American Heart Association and the American Diabetes Association.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2_e9yUNkzrtkkNKmn7YtCU
September 01, 2012 - cardiovascular morbidity and mortality in adults without known
CVD, hypertension, hyperlipidemia, or diabetes … Population: General adult population without a known diagnosis
of hypertension, diabetes, hyperlipidemia … available to quantify a person’s 10-year risk
for cardiac events, such as the Framingham-based Adult Treatment … It does not ap-
ply to adults who have known CVD, hypertension, hyper-
lipidemia, or diabetes. … The
Framingham-based Adult Treatment Panel III calculator
(available at http://hp2010.nhlbihin.net/atpiii
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
October 07, 2013 - sex, smoking status, race/ethnicity, 10-year cardiovascular risk, or related risk conditions (e.g., diabetes … age, sex, smoking status, race/ethnicity, 10-year cardiovascular risk, related risk conditions (e.g., diabetes … available cardiovascular risk prediction tools commonly used in practice are good candidates to guide therapeutic … nonoral, nontablet forms of aspirin; exposure of less than 12 months
Comparisons
Placebo or no treatment
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2012%20(2).pdf
November 01, 2012 - cascade of additional follow-up tests (some of which are invasive
and could cause harm) and unnecessary treatments … Potential harms also include side effects or complications of
treatments. … (Grade: D)
This recommendation applies to postmenopausal women who are considering hormone
therapy … Screening and Treatment for Depression in Children
3. … Curry’s health
service research has focused on the use and cost effectiveness of tobacco cessation treatments
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening-september-2016
September 25, 2014 - ‡
Other treatments or combinations
Comparisons
KQs 1, 4: Screened vs. nonscreened … –5: No comparison; nonconcordant historical controls; comparisons with screening tests or treatments … will be defined based on an initial scan of the published literature, but may include persons with diabetes … 9 months, isoniazid twice weekly by directly observed therapy for 6 or 9 months, rifampin daily for … 4 months, or isoniazid plus rifapentine weekly by directly observed therapy for 3 months.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan15/depression-in-children-and-adolescents-screening
September 15, 2013 - attention deficit hyperactivity disorder, anxiety disorders) or chronic physical health conditions (e.g., diabetes … norepinephrine-dopamine reuptake inhibitors (NDRIs), or complementary and alternative medicine (CAM) treatments … sertraline, citalopram, and escitalopram
Psychotherapy interventions:
Cognitive-behavioral therapy … Paroxetine
SNRIs, NDRIs, other types of off-label pharmacological interventions
Other therapy … :
CAM
Electroconvulsive therapy
Other interventions that are not primary
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/vmHooQ6ABG9CagdUXv2_rx
August 25, 2021 - Dyslipidemia
due to homozygous FH or secondary causes (such as diabetes,
Clinical Review & Education … USPSTF reviewed 22 fair- to good-quality trials (n = 2257)
examining the effectiveness of lipid-lowering treatments … good-quality trials (n = 1008) examining the
effectiveness of various nonpharmacologic lipid-lowering
treatments … A fair-quality observational study (n = 9393) evaluating the as-
sociation of statins and new-onset diabetes … showed no difference
in new diabetes diagnoses over up to 9 years of follow-up in indi-
viduals taking
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/usptf-annual-report-congress-2018%20(1).pdf
January 01, 2018 - identifying tools that can accurately assess people’s
risk for a specific disease; and the effectiveness of treatments … Persons who have a family history
of diabetes, have a history of gestational diabetes or polycystic … Considerations for Implementation: To determine whether a patient is a candidate for statin
therapy, … Considerations for Implementation: To determine whether a patient is a candidate for statin
therapy, … D
Hormone Therapy With Combined Estrogen and Progestin in Postmenopausal Women:
Primary Prevention
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening
May 02, 2023 - 25 Some evidence from observational studies has explored the association between poorly controlled diabetes … However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes … tuberculosis exposure, HIV infection, risk factors increasing risk of progression to active disease (such as diabetes … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/unhealthy-alcohol-use-adolescents-adults-behavioral-counseling-interventions
February 01, 2024 - how structural and social determinants of health affect risk for unhealthy alcohol use and access to treatment … not generalizable to primary care (e.g., psychiatric inpatients, persons who are court-mandated to treatment … Counseling interventions can vary in their approach (e.g., 12-step program, cognitive behavioral therapy … , or motivational enhancement therapy), specific strategies, delivery method (e.g., face-to-face, electronic … settings (e.g., diabetes management and dialysis clinics); research clinics; and office, home, or other
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan142/obstructive-sleep-apnea-in-adults-screening-january-2017
October 30, 2014 - Is there an association between OSA and incident diabetes? … assessments may occur in sleep laboratories or other settings)
KQs 4, 5, 8: For nonsurgical treatments … of allergic rhinitis or similar treatments that might secondarily improve OSA by treating another condition … Studies focusing on potential worsening of OSA that might be caused by treatments for other … or inactive mandibular advancement devices; surgery vs. sham, conservative treatment, or no treatment
-
www.uspreventiveservicestaskforce.org/uspstf/document/screening-for-hiv-in-pregnant-women-evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2013
November 15, 2012 - , with the widespread adoption of routine prenatal screening coupled with the use of more effective therapies … without treatment. … or treatment 22 , 23 , 25 . … ; not clear whether gestational diabetes was diagnosed before initiation of antiretroviral therapy … in the United States and other developed countries, except for randomized trials of antiretroviral therapies
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KdQef_VDT2kmHDX4ddNWmR
August 01, 2022 - .25 Some evidence from observational studies
has explored the association between poorly controlled diabetes … However, there is insuffi-
cient evidence on screening for and treatment of LTBI in persons
with diabetes … tuberculosis exposure, HIV infec-
tion, risk factors increasing risk of progression to active disease (such
as diabetes … Efficacy of
various durations of isoniazid preventive therapy
for tuberculosis: five years of follow-up … Adverse
events with 4 months of rifampin therapy or 9
months of isoniazid therapy for latent tuberculosis